Fig. 3From: Metformin attenuates the production and proliferative effects of prolactin induced by medroxyprogesterone acetate during fertility-sparing treatment for endometrial cancerDecidualization of stromal cell by MPA and suppression by metformin. Stromal cell treatment with/without MPA (10–6 M), cAMP (0.5 mM), and with/without metformin (1 mM) (8 days). IGFBP-1 a, PRL b, PgR c, and ERα d mRNA levels e. Columns, error bars represent the mean ± standard deviation of the mean. Met, metformin; NS, not significant (*P < 0.01, ** P < 0.05). MPA, medroxyprogesterone acetateBack to article page